{
    "predictions": [
        {
            "document": "A few studies have demonstrated that ANGPTL1 functions as a tumor suppressor gene in breast cancer  , hepatocellular carcinoma  , colorectal cancer and parathyroid carcinoma.",
            "ner_chunk": "tumor",
            "begin": 60,
            "end": 64,
            "ner_label": "Tumor_Finding",
            "ner_confidence": "0.9633",
            "icdo_code": "8000/1",
            "icdo_resolution": "tumor",
            "icdo_confidence": "0.9963"
        },
        {
            "document": "A few studies have demonstrated that ANGPTL1 functions as a tumor suppressor gene in breast cancer  , hepatocellular carcinoma  , colorectal cancer and parathyroid carcinoma.",
            "ner_chunk": "breast cancer",
            "begin": 85,
            "end": 97,
            "ner_label": "Oncological",
            "ner_confidence": "0.939",
            "icdo_code": "8010/3-C50.9",
            "icdo_resolution": "carcinoma, of breast",
            "icdo_confidence": "0.2247"
        },
        {
            "document": "A few studies have demonstrated that ANGPTL1 functions as a tumor suppressor gene in breast cancer  , hepatocellular carcinoma  , colorectal cancer and parathyroid carcinoma.",
            "ner_chunk": "hepatocellular",
            "begin": 102,
            "end": 115,
            "ner_label": "Histological_Type",
            "ner_confidence": "0.9995",
            "icdo_code": "C22.0",
            "icdo_resolution": "liver",
            "icdo_confidence": "0.3523"
        },
        {
            "document": "A few studies have demonstrated that ANGPTL1 functions as a tumor suppressor gene in breast cancer  , hepatocellular carcinoma  , colorectal cancer and parathyroid carcinoma.",
            "ner_chunk": "carcinoma",
            "begin": 117,
            "end": 125,
            "ner_label": "Cancer_Dx",
            "ner_confidence": "0.971",
            "icdo_code": "8010/3",
            "icdo_resolution": "carcinoma",
            "icdo_confidence": "0.9625"
        },
        {
            "document": "A few studies have demonstrated that ANGPTL1 functions as a tumor suppressor gene in breast cancer  , hepatocellular carcinoma  , colorectal cancer and parathyroid carcinoma.",
            "ner_chunk": "colorectal cancer",
            "begin": 130,
            "end": 146,
            "ner_label": "Oncological",
            "ner_confidence": "0.9151",
            "icdo_code": "8010/3-C18.9",
            "icdo_resolution": "carcinoma, of colon",
            "icdo_confidence": "0.0954"
        },
        {
            "document": "A few studies have demonstrated that ANGPTL1 functions as a tumor suppressor gene in breast cancer  , hepatocellular carcinoma  , colorectal cancer and parathyroid carcinoma.",
            "ner_chunk": "parathyroid carcinoma",
            "begin": 152,
            "end": 172,
            "ner_label": "Oncological",
            "ner_confidence": "0.8334",
            "icdo_code": "8010/3-C75.0",
            "icdo_resolution": "carcinoma, of parathyroid gland",
            "icdo_confidence": "0.1392"
        },
        {
            "document": "TRAF6 is a putative oncogene in a variety of cancers including  bladder cancer , and skin cancer. WWP2 appears to regulate the expression of the well characterized tumor suppressor phosphatase and tensin homolog (PTEN) in endometrial cancer and squamous cell carcinoma.",
            "ner_chunk": "cancers",
            "begin": 45,
            "end": 51,
            "ner_label": "Oncological",
            "ner_confidence": "0.962",
            "icdo_code": "8000/3",
            "icdo_resolution": "cancer",
            "icdo_confidence": "0.9045"
        },
        {
            "document": "TRAF6 is a putative oncogene in a variety of cancers including  bladder cancer , and skin cancer. WWP2 appears to regulate the expression of the well characterized tumor suppressor phosphatase and tensin homolog (PTEN) in endometrial cancer and squamous cell carcinoma.",
            "ner_chunk": "bladder cancer",
            "begin": 64,
            "end": 77,
            "ner_label": "Oncological",
            "ner_confidence": "0.92655003",
            "icdo_code": "8010/3-C67.9",
            "icdo_resolution": "carcinoma, of bladder",
            "icdo_confidence": "0.1117"
        },
        {
            "document": "TRAF6 is a putative oncogene in a variety of cancers including  bladder cancer , and skin cancer. WWP2 appears to regulate the expression of the well characterized tumor suppressor phosphatase and tensin homolog (PTEN) in endometrial cancer and squamous cell carcinoma.",
            "ner_chunk": "skin cancer",
            "begin": 85,
            "end": 95,
            "ner_label": "Oncological",
            "ner_confidence": "0.8052",
            "icdo_code": "8010/3-C44.9",
            "icdo_resolution": "carcinoma, of skin",
            "icdo_confidence": "0.1407"
        },
        {
            "document": "TRAF6 is a putative oncogene in a variety of cancers including  bladder cancer , and skin cancer. WWP2 appears to regulate the expression of the well characterized tumor suppressor phosphatase and tensin homolog (PTEN) in endometrial cancer and squamous cell carcinoma.",
            "ner_chunk": "tumor",
            "begin": 164,
            "end": 168,
            "ner_label": "Oncological",
            "ner_confidence": "0.9592",
            "icdo_code": "8000/1",
            "icdo_resolution": "tumor",
            "icdo_confidence": "0.9963"
        },
        {
            "document": "TRAF6 is a putative oncogene in a variety of cancers including  bladder cancer , and skin cancer. WWP2 appears to regulate the expression of the well characterized tumor suppressor phosphatase and tensin homolog (PTEN) in endometrial cancer and squamous cell carcinoma.",
            "ner_chunk": "endometrial cancer",
            "begin": 222,
            "end": 239,
            "ner_label": "Oncological",
            "ner_confidence": "0.96370006",
            "icdo_code": "8380/3",
            "icdo_resolution": "endometrioid carcinoma",
            "icdo_confidence": "0.1140"
        },
        {
            "document": "TRAF6 is a putative oncogene in a variety of cancers including  bladder cancer , and skin cancer. WWP2 appears to regulate the expression of the well characterized tumor suppressor phosphatase and tensin homolog (PTEN) in endometrial cancer and squamous cell carcinoma.",
            "ner_chunk": "squamous cell",
            "begin": 245,
            "end": 257,
            "ner_label": "Histological_Type",
            "ner_confidence": "0.9893",
            "icdo_code": "805-808",
            "icdo_resolution": "squamous cell neoplasms",
            "icdo_confidence": "0.2989"
        },
        {
            "document": "TRAF6 is a putative oncogene in a variety of cancers including  bladder cancer , and skin cancer. WWP2 appears to regulate the expression of the well characterized tumor suppressor phosphatase and tensin homolog (PTEN) in endometrial cancer and squamous cell carcinoma.",
            "ner_chunk": "carcinoma",
            "begin": 259,
            "end": 267,
            "ner_label": "Cancer_Dx",
            "ner_confidence": "0.994",
            "icdo_code": "8010/3",
            "icdo_resolution": "carcinoma",
            "icdo_confidence": "0.9625"
        }
    ]
}